GOOG vs MRK: Which Is the Better Buy?
Side-by-side comparison of Alphabet Inc. and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-13.
Alphabet Inc. · Communication Services
$355.03
-17.2% upside to fair value
Grade D
High Quality
VS
Merck & Co., Inc. · Healthcare
$113.87
-12.1% upside to fair value
Grade D
High Quality
QuantHub Verdict
MRK has more upside to fair value
(-12.1%).
GOOG trades at a lower forward P/E
(27.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
GOOG |
MRK |
| Current Price |
$355.03 |
$113.87 |
| Fair Value Estimate |
$294.10 |
$100.14 |
| Upside to Fair Value |
-17.2%
|
-12.1%
|
| Market Cap |
$4,320.1B |
$281.2B |
| Forward P/E |
27.0x
|
32.0x
|
| EV / EBITDA |
20.0x
|
17.3x
|
| Price / Sales |
10.2x
|
4.3x
|
| Price / FCF |
67.0x
|
19.9x
|
| Revenue Growth YoY |
+21.8%
|
+4.3%
|
| Gross Margin |
60.4%
|
75.9%
|
| Operating Margin |
32.7%
|
27.6%
|
| Return on Equity |
39.0%
|
17.9%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
1.49%
|
5.02%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Alphabet Inc. operates as a global leader in internet content and information services, primarily through its dominant search engine, advertising platforms, and cloud services. The company exhibits high business quality with a durable competitive moat supported by strong network effects, brand recognition, and intangible assets. Alphabet's financials reflect robust profitability with a net margin…
Merck & Co., Inc. is a leading global healthcare company specializing in pharmaceuticals, vaccines, and animal health products. Its business quality is high, supported by a durable competitive moat anchored in the dominant global position of Keytruda in PD-1/PD-L1 oncology, a strong vaccines portfolio including Gardasil, and scale in R&D and manufacturing. The company benefits from a seasoned lea…
Accumulation Zones
| Metric |
GOOG |
MRK |
| Zone Low |
$220.58 |
$75.11 |
| Zone High |
$249.99 |
$85.12 |
| In Buy Zone? |
No
|
No
|